Shashank Upadhye, a founding partner of Upadhye Tang LLP an IP & FDA boutique law firm in Chicago and author of Generic Pharmaceutical Patent & FDA Law, a textbook now in its 14th edition, served as chief in-house counsel at three leading pharmaceutical companies: Apotex, Inc., Sandoz-Novartis, and Eon Labs, Inc
(Note: some answers in this piece have been trimmed for length and clarity.) Overview Lets start off with the basics
*6,7 RESTORE-G: RESTORE-G was a real-world analysis in insulin-nave adults with type 2 diabetes mellitus (T2DM) previously treated with GLP-1 receptor agonists (GLP-1 RA) oral antidiabetic drugs (OADs), examining therapy intensification through three approaches involving basal insulin analogues 8 : Starting basal insulin and discontinuing GLP-1 RA Adding basal insulin to ongoing GLP-1 RA Initiating a FRC product and discontinuing current GLP-1 RA 1
Given the multiple sites of GLP1R expression, many of its effects across the many tissues expressing it are yet to be fully understood
Mechanosensitive ion channels (MICs) are a crucial class of mechanoreceptors that directly detect changes in mechanical stress across the cytomembrane, translating these variations into altered ion permeability and thereby modulating membrane potential and intracellular ion concentrations[164]
